Skip to content

Mind Body Intervention for Chronic Migraine Headaches

RecruitingNot applicableNCT06690060
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The goal of this exploratory study is to test a mind-body interventional approach for the treatment of chronic migraines. The main goal is to obtain feasibility information on the protocol which has been used in other similar conditions. We will also evaluate multiple measurement tools in order to optimize a follow-up pilot study evaluating the impact of the protocol on migraines.

Study details

Official title
Mind Body Intervention for Chronic Migraine Headaches
Conditions
Interventions
  • Behavioral: Mind-Body Intervention
Sponsor
Beth Israel Deaconess Medical Center
Start date
2024-11-15
Primary completion
2027-11
Sex
All
Age range
from 18 Years
Results posted
No results posted in this snapshot
Countries
United States
Total sites listed
2

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Adult (≥ 18 years of age) 2. Previously diagnosed with migraine headache based on ICHD-3 beta criteria 91 3. A score of ≥ 50 on the Headache Impact Test-6 self-report survey (moderate impact) 92 4. Presence of migraine headaches at least 5 days per month 5. Willing to engage in a Mind-Body intervention 6. Willing/able to participate in remote sessions Exclusion Criteria: 1. Known history or suspicion of headaches due to organic cause (e.g. cancer, sinus infection, head trauma, cerebrovascular disease) 2. Diagnosis of other chronic pain syndromes that may cloud assessments (e.g. fibromyalgia, chronic idiopathic neck pain) 3. Diagnosis of cognitive impairment or dementia 4. Active addiction disorder, e.g. cocaine or IV heroin use, that would interfere with study participation 5. Major psychiatric comorbidity (e.g., schizophrenia). Anxiety and mild-moderate depression are not considered exclusions.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06690060